© 2020 MJH Life Sciences and AJMC. All rights reserved.
© 2020 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
December 20, 2011
Recent legislative action and private sector innovation, driven by the unsustainability of the current system, may gradually create a business case for performance improvement.
Among a Medicare population, use of 3 self-reported health items improves predicted inpatient admissions and healthcare costs when used with risk-prediction model.
Physicians prescribe more broadly than commonly perceived. Although most physicians have a favorite drug, they are not reluctant to try new therapies.
Health plans have made substantial progress in the collection of language data and many are offering options for language services.
We found that, in 2008, variations across Texas in total spending and inpatient utilization are similar in Blue Cross Blue Shield of Texas and Medicare.
December 22, 2011
An approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.
In treatment of depression with adjunctive aripiprazole, early improvement (week 2) was a significant predictor of remission, and lack of improvement was associated with nonremission.
December 21, 2011
An insurance benefit that provides percutaneous coronary intervention patients with a discharge supply of antiplatelet medication could result in cost savings for insurers.
This study empirically examines whether market competition is a potential driver of hospital performance on the key evidence-based Joint Commission heart-failure quality indicators.